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Abstract: Objectives: To assess the effectiveness of permanent bilateral occlusion of uterine arteries as a treatment 
modality of abnormal uterine bleeding. 
Design: prospective single arm study. 
Setting: Done in Mansoura university hospital, department of Obstetrics and gynecology and private center (Mansoura 
Integrated Fertility Center- MIFC) Mansoura- Egypt from October 2011to October 2015 including the study and follow up 
period. 
Patients: The study includes One hundred eighteen (118) premenopausal patients followed up for thirty six months. All of 
them completed their families and needing to preserve their uteri. 68.6 % of them experienced failed medical treatment.  
Intervention: permanent bilateral uterine arteries occlusion in management of abnormal uterine bleeding.  
Measurements: The primary outcome measures were patient satisfaction, Quality of life and improvements of pain and 
bleeding compared with pretreatment one. Secondary outcome measures included postoperative pain, complications, 
secondary interventions, and failures. 
Results: One hundred and nine patients completed follow up for three years 109/118 (92.4%) reported their satisfaction 
as indicated by reduction in days of menstrual flow per cycle (3.7 ± 2.8 vs. 8.8 ± 6.2 days, p < 0.0001) also, significant 
improvement in quality of life scores (9 ± 1.2 vs. 2.6 ± 1.8 p < 0.0001). with a variable failure rate varies from 5.6% at 6 
months to 3.9% at 36 months follow up.  
Conclusion: permanent bilateral uterine arteries occlusion may be a good alternative to radical surgery in management 
of abnormal uterine bleeding.  
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INTRODUCTION 
Abnormal uterine bleeding is a common problem [1] 
and its management can be complex [2]. Menstrual 
disorders are a common indication for medical visits 
among women of reproductive age [3] and heavy 
menstrual bleeding affects up to 30% of women 
throughout their reproductive lifetime [4]. These 
complaints may significantly affect quality of life [5] 
result in time off work [6] lead to surgical intervention 
including hysterectomy [7] and ultimately have a 
significant impact on the health care system [8]. 
There are 9 main categories, which are arranged 
according to the acronym PA LM-COEIN. In general, 
the components of the PALM group are discrete 
[structural] entities that can be measured visually with 
imaging technique s and/or histopathology, whereas 
the COEIN group is related to entities that are not 
defined by imaging or histopathology [non structural], 
the two most common causes are structural  
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abnormalities of the reproductive system and ovulation 
disorders [9]. 
Although Hysterectomy is the definitive treatment 
for excessive uterine bleeding in women who no longer 
wish to conceive but carry many disadvantages include 
increased number of adverse effects, longer recovery 
time, and higher initial health care costs compared with 
uterine sparing procedures [10, 11]. Hysterectomy also 
may be associated with ovarian failure nearly four 
years earlier than expected [12]. 
Alternate minimally invasive techniques have 
emerged because advantages of these procedures 
over hysterectomy as they do not involve surgical 
removal of the uterus; therefore, the operative and 
recovery times are shorter and the complication rates 
seem to be lower and some may be performed as 
outpatient procedures, avoiding the hospital stay 
required after hysterectomy [13]. One of these 
techniques is permanent uterine occlusion either by 
laparoscopic clips or uterine artery embolization, both 
laparoscopic occlusion of the uterine vessel and 
embolization appear to improve symptoms associated 
with uterine leiomyomata in the majority of patients 
[14]. In this study we tried other technique to perform 
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permanent uterine arteries occlusion avoiding highly 
skillful laparoscopic maneuver or costly, invasive 
uterine artery embolization and also, it's many 
disadvantages as deep venous thrombosis or 
pulmonary embolism [15] and post embolization 
syndrome [16]. 
PATIENTS AND METHODS 
This study was carried out in Mansoura university 
hospital, department of Obstetrics and Gynecology and 
private center (Mansoura integrated fertility center) 
including one hundred eighteen (118) patients in the 
period from October 2011 till October 2015 and follow 
up for 36 months including the period of the study. 
Inclusion Criteria includes premenopausal with 
abnormal uterine bleeding and completed their families 
having non pathologic endometrium (biopsy in 
preceding 6 months) and may have uterine intramural 
myoma/s the largest one not exceeding 150 ml in 
volume and away from uterine cavity by at least 1cm 
and /or adenomyosis. Exclusion Criteria includes 
patients wishing future fertility, endometrial sampling 
not done or more than 6 months or myoma 
encroaching or distorting cavity or larger than 150 ml in 
volume. The primary outcome measure was patient 
satisfaction, Quality of life and improvements of 
bleeding compared with pretreatment one. Secondary 
outcome measures included postoperative pain, 
complications, secondary interventions, and failures. All 
eligible patients attended a consultation by a 
gynecologist, which included a gynecological 
examination, ultrasonography and office hysteroscopy 
in suspected uterine cavity lesion(s). Patients were 
informed about the possible risks and benefits of the 
treatment and a written consent was obtained from 
each patient. The study was approved by the local 
research ethics committee. History taking, clinical 
examination, body mass index (BMI), and vaginal 
examination were undertaken as well as abdominal 
and transvaginal ultrasound scans. Basic investigations 
included urine analysis, complete blood count, liver and 
kidney functions, and fasting and postprandial plasma 
glucose levels. The procedure was carried out in the 
operating theatre under regional spinal or local 
infiltration anesthesia plus sedation and analgesics. 
Uterine artery ligation was performed during 
laparotomy. The uterus was pulled up to expose the 
lower part of the broad ligament. Pulsations of the 
uterine artery were felt near the junction of the body 
and the cervix. Nylon tape which is white polyester 
5mm non-absorbable permanent occlusion suture ( 
UNISTER®, UNIMED KINGDOM OF SAUDIA 
ARABIA) was passed around the artery and through 1–
2cm of the myometrium at the level where a transverse 
lower uterine segment incision would be made, and the 
procedure was repeated on the other side. Uterine 
arteries Doppler was performed 48 hours later to 
ensure complete occlusion. A standardized 
questionnaire was used at all appointments. The 
questionnaire explored their menstrual pattern, 
dysmenorrhea and satisfaction before and after the 
procedure using a 10 cm visual analogue scale (VAS) 
with a ‘‘0, much worse’’ and ‘‘10, much better’’ at 
opposite ends and the mid-point representing no 
change. Participants were asked to grade changes in 
amount of bleeding, pain and satisfaction as better, 
worse, or unchanged. Adverse events were recorded 
for each patient intra-operatively, during the hospital 
stay and during outpatient visits till 36 months. All 
subsequent surgical and medical interventions, as well 
as readmission to the hospital or prolonged 
hospitalization were recorded. Total improvement of 
symptoms at the 36-month follow-up was defined as 
no, little or moderate bleeding. Clinical failure was 
defined as persistent bleeding requiring secondary 
treatment or no improvement at the 6-month follow-up. 
Statistical analysis was performed using SPSS 
12.0, IL, Chicago and the questionnaire were entered 
into a Microsoft Access Database. Results were 
analyzed using frequency tables, Student’s t test and 
Chi-squared test, the data are presented as mean 
values for normal distributed data and as median 
values for skewed data. A significance level of 0.05 
was used for all tests. To achieve the power of the 
study and sample size we use PASS 2008, and a 
sample size of 118 patients give power 94 % [17-19]. 
RESULTS 
During the study and follow up period (2011–2015), 
118 women underwent permanent uterine occlusion 
using unister® 5mm; their mean age was 40.6 ± 3.16 
years (range 34-45). The procedure was performed 
under regional anesthesia in 97 cases (82.2%) and 
21cases (17.8%) done with local infiltration anesthesia 
plus analgesics (Table 1). All 118 women were seen or 
have returned a completed questionnaire, giving a 
response rate of (100%) after 6 months and 109 
women only completed 36 months follow up. 81 women 
(68.6%) had undergone a trial of medical treatment 
before the procedure (Table 1). Quality-of-life (QOL) 
scores and the menstrual bleeding pattern were 
measured before and at 6, 12, 24 and 36 months 
following treatment. The mean QOL scores before 
treatment was 2.6 ± 1.8 compared with 9 ± 1.2 at 36 
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months after treatment (p < 0.0001) as shown in Table 
2. There was also a significant improvement in 
menstrual pattern from 8.8 ± 6.2 days before treatment 
to 3.7 ± 2.8 at 36 months after treatment (p < 0.0001) 
and also, number of pads/day changed from 12.6 ± 6.2 
before treatment to 3 ± 2.7 after treatment (p < 0.0001) 
as shown in Table 2. Also, there was an observed 
improvement in the bleeding, pain and patients’ 
satisfaction rate by 88.9 %, 92.4 % and 92.5 % 
respectively at 36 months as shown in Table 3, also, 
(5.6%) patients reported clinical failure (no 
improvement) At 6-months follow up, and (3.9%) at 36 
months follow up. 
Table 1: Baseline Parameters of the Studied Group (n = 
118 Patients) 
Item Parameter 
Age (years) 
BMI 
Parity 
Preoperative haemoglobin concentration (g % ) 
Patients with bleeding 
Patients with pain (dysmenorrhea)  
Patients with pain + bleeding 
Type of anaesthesia 
(a) spinal anaesthesia 
(b) Local infiltration anaesthesia + analgesia  
Attempted medical treatments before procedure 
40.6 ± 3.19 
24 ± 3.15 
3 ± 1.9 
10.5 ± 0.5 
89 (75.4 %) 
29 (24.5 %) 
53 (44.9 %) 
 
97 (82.2 %) 
21 (17.8 %) 
81 (68.6 %) 
 
Table 2: Change in Menstrual Bleeding and Quality of 
Life (QOL) Scores 36 Months after the 
Procedure 
Menstrual 
Bleeding 
Before 
Procedure 
After 
Procedure P value 
Days/cycle 
Mean ± SD 
Pads/day 
Mean ± SD 
QOL scores 
Mean ± SD 
 
8.8 ± 6.2 
 
      12.6 ± 6.2 
 
 2.6 ± 1.8 
 
3.7 ± 2.8 
 
         3 ± 2.7 
 
9 ± 1.2 
 
<0.0001 
 
<0.0001 
 
<0.0001 
 
Table 3: Clinical Outcome at Different Follow up 
Intervals 
Item Six Months  (n =118) Three Years  (n = 109) 
Bleeding 49.7 % 88.9% 
Pain 
(dysmenorrhea) 58.7% 92.4% 
Patient’s 
satisfaction 66.7% 92.5% 
Clinical failure 5.6% 3.9% 
DISCUSSION 
This study aims to provide a novel modality in 
permanent uterine arteries occlusion which is not 
difficult, not costly, needs no highly expert personnel 
and devoid of serious complications like the other 
famous methods like uterine arteries embolization or 
laparoscopic uterine arteries occlusion. Our study 
revealed an encouraging and satisfactory result 
although 81 women (68.6 %) tried medical treatment 
before the proposed procedure. There is improvement 
in amount of bleeding and this manifested by reduction 
in duration of the cycles from 8.8 ± 6.2 days to 3.7 ± 
2.8 days with p value < 0.0001, also by reduction in 
numbers of pads /day from 12.6 ± 6.2 to 3 ± 2.7 with p 
value < 0.0001 and improvement in quality of life and 
patient satisfaction with rising score from 2.6 ± 1.8 to 9 
± 1.2 with p value < 0.0001 and these results come in 
agreement with Jun [20], Gupta [21] and 
Panagiotopoulou [22]. While our results come superior 
than the results of Matteson [23]. Also, failure rate of 
the technique after 36 months in our study appears 
comparable with that of Martin [24] and Toor [25] 
however their series included larger number of cases. 
CONCLUSION 
Permanent uterine arteries occlusion using non-
absorbable 5mm tape suture is an effective, not difficult 
and promising procedure which considered a good 
alternative to highly expert, highly complicated and 
costly other famous permanent uterine arteries 
occlusion procedures. 
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